{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:35:07Z","timestamp":1791434107180,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":855,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1111\/jth.14836","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T14:05:26Z","timestamp":1586959526000},"page":"1562-1568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Anticoagulant therapy for splanchnic vein thrombosis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-7304","authenticated-orcid":false,"given":"Marcello","family":"Di Nisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-3214","authenticated-orcid":false,"given":"Emanuele","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8922-8823","authenticated-orcid":false,"given":"Nicoletta","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Beyer\u2010Westendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14836_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/jth.14836_bb0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1111\/jth.14836_bb0020","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/jth.14836_bb0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jth.14836_bb0030","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd\u2010Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14836_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0040","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long\u2010term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jth.14836_bb0045","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S2352-3026(18)30133-9","article-title":"Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population\u2010based cohort study","volume":"5","author":"Sogaard","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1111\/jth.14836_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2016.02.024","article-title":"Survival after splanchnic vein thrombosis: a 20\u2010year nationwide cohort study","volume":"141","author":"S\u00f8gaard","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14836_bb0055","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0060","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","article-title":"Portal hypertension\u2010related complications after acute portal vein thrombosis: impact of early anticoagulation","volume":"6","author":"Turnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0065","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/jth.14836_bb0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"10.1111\/jth.14836_bb0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0000000000001061","article-title":"Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation","volume":"30","author":"Guillaume","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow\u2010up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/jth.14836_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejim.2014.09.004","article-title":"Clinical implications of the hyperdynamic syndrome in cirrhosis","volume":"25","author":"Licata","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1111\/jth.14836_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2018.01.032","article-title":"Low\u2010molecular\u2010weight heparin treatment for portal vein thrombosis in liver cirrhosis: efficacy and the risk of hemorrhagic complications","volume":"163","author":"Kwon","year":"2018","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14836_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non\u2010neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vascul Pharmacol"},{"key":"10.1111\/jth.14836_bb0105","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jth.12930","article-title":"Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study","volume":"13","author":"Riva","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14836_bb0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00268-017-4185-2","article-title":"Thromboembolic events following splenectomy: risk factors, prevention, management and outcomes","volume":"42","author":"Rottenstreich","year":"2018","journal-title":"World J Surg"},{"key":"10.1111\/jth.14836_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.soard.2016.05.012","article-title":"Abdominal thrombotic complications following bariatric surgery","volume":"13","author":"Rottenstreich","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1111\/jth.14836_bb0120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3109\/00365548.2010.508464","article-title":"Pylephlebitis: an overview of non\u2010cirrhotic cases and factors related to outcome","volume":"42","author":"Kanellopoulou","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/jth.14836_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MIB.0b013e31827eea5f","article-title":"Portomesenteric vein thrombosis in patients with inflammatory bowel disease","volume":"19","author":"Landman","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/jth.14836_bb0130","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14836_bb0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","article-title":"Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis","volume":"16","author":"Hollingshead","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/jth.14836_bb0140","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/01.RVI.0000182156.71059.B7","article-title":"Transhepatic catheter\u2010directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis","volume":"16","author":"Kim","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/jth.14836_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","article-title":"Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature","volume":"40","author":"Sharma","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/jth.14836_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.avsg.2016.02.019","article-title":"Postoperative catheter\u2010directed thrombolysis versus systemic anticoagulation for acute superior mesenteric venous thrombosis","volume":"35","author":"Yang","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1111\/jth.14836_bb0155","first-page":"99","article-title":"Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14836_bb0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.14836_bb0165","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer\u2010associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14836_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/jth.14836_bb0175","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/MEG.0b013e328357d5d4","article-title":"Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis","volume":"24","author":"Amitrano","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.25677","article-title":"Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases","volume":"95","author":"Sant'Antonio","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.14836_bb0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2006.09.030","article-title":"Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long\u2010term follow\u2010up","volume":"5","author":"Orr","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/jth.14836_bb0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non\u2010cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14836_bb0195","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry","volume":"3","author":"Riva","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1111\/jth.14836_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"Tufano","year":"2018","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14836_bb0205","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long\u2010term outcome of Budd\u2010Chiari syndrome with a step\u2010wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/jth.14836_bb0210","first-page":"581","article-title":"Feasibility of anticoagulation in patients of Budd\u2010chiari syndrome with gastroesophageal varices and portal hypertension","volume":"2","author":"Dabbous","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology Research"},{"key":"10.1111\/jth.14836_bb0215","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd\u2010Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/jth.14836_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3748\/wjg.14.278","article-title":"Changing spectrum of Budd\u2010Chiari syndrome in India with special reference to non\u2010surgical treatment","volume":"14","author":"Amarapurkar","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/jth.14836_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jhep.2010.06.019","article-title":"Bleeding in patients with Budd\u2010Chiari syndrome","volume":"54","author":"Rautou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/jth.14836_bb0230","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jgh.14843","article-title":"Dabigatran as an oral anticoagulant in patients with Budd\u2010Chiari syndrome post\u2010percutaneous endovascular intervention","volume":"35","author":"Sharma","year":"2019","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14836","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622013393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:28:06Z","timestamp":1761535686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622013393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1538783622013393"],"URL":"https:\/\/doi.org\/10.1111\/jth.14836","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulant therapy for splanchnic vein thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}